Allergy Therapeutics first-half revenue up 7%
Commercial biotechnology company Allergy Therapeutics said first-half revenue had increased 7%, in line with its expectations, on strong performance in Germany, Austria, Netherlands and Switzerland....
Wed, 13/01/2021 - 09:09